RECEPTORS, FIBROBLAST GROWTH FACTOR
Clinical trials for RECEPTORS, FIBROBLAST GROWTH FACTOR explained in plain language.
Never miss a new study
Get alerted when new RECEPTORS, FIBROBLAST GROWTH FACTOR trials appear
Sign up with your email to follow new studies for RECEPTORS, FIBROBLAST GROWTH FACTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer treatment delivers drug straight to the tumor
Disease control OngoingThis study tests a drug called erdafitinib, placed directly into the bladder using a special delivery system, for people with non-muscle-invasive or muscle-invasive bladder cancer. The trial has four parts to find the best dose and check safety and effectiveness. About 235 partic…
Matched conditions: RECEPTORS, FIBROBLAST GROWTH FACTOR
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New bladder cancer drug delivery system tested in small japanese study
Disease control OngoingThis early-stage study tests a new treatment called TAR-210 in 5 Japanese patients with a type of bladder cancer that has specific genetic changes (FGFR mutations). The treatment is placed directly into the bladder to deliver the drug erdafitinib. The main goal is to see if it is…
Matched conditions: RECEPTORS, FIBROBLAST GROWTH FACTOR
Phase: PHASE1 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC